Genetic basis of diabetic kidney disease and other diabetic complications

Current Opinion in Genetics and Development

Volumn 50, Issue , 2018, Pages 17-24

  Sandholm, Niina ^a,b,c   Groop, Per Henrik ^a,b,c,d  

^a FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; COMORBIDITY; DIABETIC COMPLICATION; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; END STAGE RENAL DISEASE; EXOME; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GLYCEMIC CONTROL; HEREDITY; HUMAN; LONG TERM CARE; MOLECULAR MECHANICS; MORTALITY; NEUROPATHY; PHENOTYPE; PREMATURE MORTALITY; PRIORITY JOURNAL; REVIEW; KIDNEY; PATHOLOGY;

CDCA7 PROTEIN, HUMAN; DNA LIGASE; DNA METHYLTRANSFERASE; MGMT PROTEIN, HUMAN; NUCLEAR PROTEIN; SP3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SP3; TUMOR SUPPRESSOR PROTEIN;

CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KIDNEY; NUCLEAR PROTEINS; SP3 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEINS;

EID: 85042232662     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2018.01.002     Document Type: Review

References (51)

1. Ogurtsova, K., da Rocha Fernandes, J.D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N.H., Cavan, D., Shaw, J.E., Makaroff, L.E., IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 128 (2017), 40–50 pii:S0168-8227(17)30375-3.
2. Groop, P.H., Thomas, M.C., Moran, J.L., Wadèn, J., Thorn, L.M., Mäkinen, V.P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä O., Forsblom, C., FinnDiane Study Group. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 58 (2009), 1651–1658.
3. Seaquist, E.R., Goetz, F.C., Rich, S., Barbosa, J., Familial clustering of diabetic kidney disease. N Engl J Med 320 (1989), 1161–1165.
4. Borch-Johnsen, K., Norgaard, K., Hommel, E., Mathiesen, E.R., Jensen, J.S., Deckert, T., Parving, H.H., Is diabetic nephropathy an inherited complication. Kidney Int 41 (1992), 719–722.
5. Harjutsalo, V., Katoh, S., Sarti, C., Tajima, N., Tuomilehto, J., Population-based assessment of familial clustering of diabetic nephropathy in type 1 diabetes. Diabetes 53 (2004), 2449–2454.
6. Sandholm, N., Van Zuydam, N., Ahlqvist, E., Juliusdottir, T., Deshmukh, H.A., Rayner, N.W., Di Camillo, B., Forsblom, C., Fadista, J., Ziemek, D., Salem, R.M., Hiraki, L.T., Pezzolesi, M., Tregouet, D., Dahlstrom, E., Valo, E., Oskolkov, N., Ladenvall, C., Marcovecchio, M.L., Cooper, J., Sambo, F., Malovini, A., Manfrini, M., McKnight, A.J., Lajer, M., Harjutsalo, V., Gordin, D., Parkkonen, M., FinnDiane Study Group, Tuomilehto, J., Lyssenko, V., McKeigue, P.M., Rich, S.S., Brosnan, M.J., Fauman, E., Bellazzi, R., Rossing, P., Hadjadj, S., Krolewski, A., Paterson, A.D., DCCT/EDIC Study Group, Florez, J.C., Hirschhorn, J.N., Maxwell, A.P., GENIE Consortium DD, Cobelli, C., Colhoun, H.M., Groop, L., McCarthy, M.I., Groop, P.H., SUMMIT Consortium, The genetic landscape of renal complications in type 1 diabetes. J Am Soc Nephrol 28 (2017), 557–574, 10.1681/ASN.2016020231 GWAS on DKD with multiple phenotypic definitions showing genetic correlation with BMI, T2D and smoking cessation, as well as and whole exome sequencing on DKD.
7. Mooyaart, A., Valk, E.J.J., van Es, L., Bruijn, J., de Heer, E., Freedman, B., Dekkers, O., Baelde, H., Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia 54 (2011), 544–553.
8. Williams, W.W., Salem, R.M., McKnight, A.J., Sandholm, N., Forsblom, C., Taylor, A., Guiducci, C., McAteer, J.B., McKay, G.J., Isakova, T., Brennan, E.P., Sadlier, D.M., Palmer, C., Soderlund, J., Fagerholm, E., Harjutsalo, V., Lithovius, R., Gordin, D., Hietala, K., Kyto, J., Parkkonen, M., Rosengard-Barlund, M., Thorn, L., Syreeni, A., Tolonen, N., Saraheimo, M., Waden, J., Pitkaniemi, J., Sarti, C., Tuomilehto, J., Tryggvason, K., Osterholm, A.M., He, B., Bain, S., Martin, F., Godson, C., Hirschhorn, J.N., Maxwell, A.P., Groop, P.H., Florez, J.C., GENIE Consortium, Association testing of previously reported variants in a large case–control meta-analysis of diabetic nephropathy. Diabetes 61 (2012), 2187–2194, 10.2337/db11-0751.
9. Pezzolesi, M.G., Poznik, G.D., Mychaleckyj, J.C., Paterson, A.D., Barati, M.T., Klein, J.B., Ng, D.P.K., Placha, G., Canani, L.H., Bochenski, J., Waggott, D., Merchant, M.L., Krolewski, B., Mirea, L., Wanic, K., Katavetin, P., Kure, M., Wolkow, P., Dunn, J.S., Smiles, A., Walker, W.H., Boright, A.P., Bull, S.B., DCCT/EDIC Research Group, Doria, A., Rogus, J.J., Rich, S.S., Warram, J.H., Krolewski, A.S., Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes 58 (2009), 1403–1410.
10. Pezzolesi, M.G., Jeong, J., Smiles, A.M., Skupien, J., Mychaleckyj, J.C., Rich, S.S., Warram, J.H., Krolewski, A.S., Family-based association analysis confirms the role of the chromosome 9q21.32 locus in the susceptibility of diabetic nephropathy. PLoS ONE, 8, 2013, e60301, 10.1371/journal.pone.0060301.
11. Freedman, B.I., Langefeld, C.D., Lu, L., Divers, J., Comeau, M.E., Kopp, J.B., Winkler, C.A., Nelson, G.W., Johnson, R.C., Palmer, N.D., Hicks, P.J., Bostrom, M.A., Cooke, J.N., McDonough, C.W., Bowden, D.W., Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans. PLoS Genet, 7, 2011, e1002150, 10.1371/journal.pgen.1002150.
12. Sandholm, N., Salem, R.M., McKnight, A.J., Brennan, E.P., Forsblom, C., Isakova, T., McKay, G.J., Williams, W.W., Sadlier, D.M., Makinen, V.P., Swan, E.J., Palmer, C., Boright, A.P., Ahlqvist, E., Deshmukh, H.A., Keller, B.J., Huang, H., Ahola, A.J., Fagerholm, E., Gordin, D., Harjutsalo, V., He, B., Heikkila, O., Hietala, K., Kyto, J., Lahermo, P., Lehto, M., Lithovius, R., Osterholm, A.M., Parkkonen, M., Pitkaniemi, J., Rosengard-Barlund, M., Saraheimo, M., Sarti, C., Soderlund, J., Soro-Paavonen, A., Syreeni, A., Thorn, L.M., Tikkanen, H., Tolonen, N., Tryggvason, K., Tuomilehto, J., Waden, J., Gill, G.V., Prior, S., Guiducci, C., Mirel, D.B., Taylor, A., Hosseini, S.M., DCCT/EDIC Research Group, Parving, H.H., Rossing, P., Tarnow, L., Ladenvall, C., Alhenc-Gelas, F., Lefebvre, P., Rigalleau, V., Roussel, R., Tregouet, D.A., Maestroni, A., Maestroni, S., Falhammar, H., Gu, T., Mollsten, A., Cimponeriu, D., Ioana, M., Mota, M., Mota, E., Serafinceanu, C., Stavarachi, M., Hanson, R.L., Nelson, R.G., Kretzler, M., Colhoun, H.M., Panduru, N.M., Gu, H.F., Brismar, K., Zerbini, G., Hadjadj, S., Marre, M., Groop, L., Lajer, M., Bull, S.B., Waggott, D., Paterson, A.D., Savage, D.A., Bain, S.C., Martin, F., Hirschhorn, J.N., Godson, C., Florez, J.C., Groop, P.H., Maxwell, A.P., New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet, 8, 2012, e1002921, 10.1371/journal.pgen.1002921.
13. Sandholm, N., McKnight, A.J., Salem, R.M., Brennan, E.P., Forsblom, C., Harjutsalo, V., Makinen, V.P., McKay, G.J., Sadlier, D.M., Williams, W.W., Martin, F., Panduru, N.M., Tarnow, L., Tuomilehto, J., Tryggvason, K., Zerbini, G., Comeau, M.E., Langefeld, C.D., Consortium, F.I.N.D., Godson, C., Hirschhorn, J.N., Maxwell, A.P., Florez, J.C., Groop, P.H., FinnDiane Study Group, the GENIE Consortium, Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes. J Am Soc Nephrol 24 (2013), 1537–1543, 10.1681/ASN.2012111122.
14. Sandholm, N., Forsblom, C., Makinen, V.P., McKnight, A.J., Osterholm, A.M., He, B., Harjutsalo, V., Lithovius, R., Gordin, D., Parkkonen, M., Saraheimo, M., Thorn, L.M., Tolonen, N., Waden, J., Tuomilehto, J., Lajer, M., Ahlqvist, E., Mollsten, A., Marcovecchio, M.L., Cooper, J., Dunger, D., Paterson, A.D., Zerbini, G., Groop, L., SUMMIT Consortium, Tarnow, L., Maxwell, A.P., Tryggvason, K., Groop, P.H., FinnDiane Study Group. Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes. Diabetologia 57 (2014), 1143–1153, 10.1007/s00125-014-3202-3.
15. Iyengar, S.K., Sedor, J.R., Freedman, B.I., Kao, W.H., Kretzler, M., Keller, B.J., Abboud, H.E., Adler, S.G., Best, L.G., Bowden, D.W., Burlock, A., Chen, Y.D., Cole, S.A., Comeau, M.E., Curtis, J.M., Divers, J., Drechsler, C., Duggirala, R., Elston, R.C., Guo, X., Huang, H., Hoffmann, M.M., Howard, B.V., Ipp, E., Kimmel, P.L., Klag, M.J., Knowler, W.C., Kohn, O.F., Leak, T.S., Leehey, D.J., Li, M., Malhotra, A., Marz, W., Nair, V., Nelson, R.G., Nicholas, S.B., O'Brien, S.J., Pahl, M.V., Parekh, R.S., Pezzolesi, M.G., Rasooly, R.S., Rotimi, C.N., Rotter, J.I., Schelling, J.R., Seldin, M.F., Shah, V.O., Smiles, A.M., Smith, M.W., Taylor, K.D., Thameem, F., Thornley-Brown, D.P., Truitt, B.J., Wanner, C., Weil, E.J., Winkler, C.A., Zager, P.G., Igo, R.P. Jr., Hanson, R.L., Langefeld, C.D., Family Investigation of Nephropathy and Diabetes (FIND), Genome-wide association and trans-ethnic meta-analysis for advanced diabetic kidney diseaseiabetes (FIND). PLoS Genet, 11, 2015, e1005352, 10.1371/journal.pgen.1005352 Trans-ethnic GWAS on DKD identified a novel locus between the SCAF8 and CNKSR3 genes.
16. Pattaro, C., Teumer, A., Gorski, M., Chu, A.Y., Li, M., Mijatovic, V., Garnaas, M., Tin, A., Sorice, R., Li, Y., Taliun, D., Olden, M., Foster, M., Yang, Q., Chen, M.H., Pers, T.H., Johnson, A.D., Ko, Y.A., Fuchsberger, C., Tayo, B., Nalls, M., Feitosa, M.F., Isaacs, A., Dehghan, A., d'Adamo, P., Adeyemo, A., Dieffenbach, A.K., Zonderman, A.B., Nolte, I.M., van der Most, P.J., Wright, A.F., Shuldiner, A.R., Morrison, A.C., Hofman, A., Smith, A.V., Dreisbach, A.W., Franke, A., Uitterlinden, A.G., Metspalu, A., Tonjes, A., Lupo, A., Robino, A., Johansson, A., Demirkan, A., Kollerits, B., Freedman, B.I., Ponte, B., Oostra, B.A., Paulweber, B., Kramer, B.K., Mitchell, B.D., Buckley, B.M., Peralta, C.A., Hayward, C., Helmer, C., Rotimi, C.N., Shaffer, C.M., Muller, C., Sala, C., van Duijn, C.M., Saint-Pierre, A., Ackermann, D., Shriner, D., Ruggiero, D., Toniolo, D., Lu, Y., Cusi, D., Czamara, D., Ellinghaus, D., Siscovick, D.S., Ruderfer, D., Gieger, C., Grallert, H., Rochtchina, E., Atkinson, E.J., Holliday, E.G., Boerwinkle, E., Salvi, E., Bottinger, E.P., Murgia, F., Rivadeneira, F., Ernst, F., Kronenberg, F., Hu, F.B., Navis, G.J., Curhan, G.C., Ehret, G.B., Homuth, G., Coassin, S., Thun, G.A., Pistis, G., Gambaro, G., Malerba, G., Montgomery, G.W., Eiriksdottir, G., Jacobs, G., Li, G., Wichmann, H.E., Campbell, H., Schmidt, H., Wallaschofski, H., Volzke, H., Brenner, H., Kroemer, H.K., Kramer, H., Lin, H., Leach, I.M., Ford, I., Guessous, I., Rudan, I., Prokopenko, I., Borecki, I., Heid, I.M., Kolcic, I., Persico, I., Jukema, J.W., Wilson, J.F., Felix, J.F., Divers, J., Lambert, J.C., Stafford, J.M., Gaspoz, J.M., Smith, J.A., Faul, J.D., Wang, J.J., Ding, J., Hirschhorn, J.N., Attia, J., Whitfield, J.B., Chalmers, J., Viikari, J., Coresh, J., Denny, J.C., Karjalainen, J., Fernandes, J.K., Endlich, K., Butterbach, K., Keene, K.L., Lohman, K., Portas, L., Launer, L.J., Lyytikainen, L.P., Yengo, L., Franke, L., Ferrucci, L., Rose, L.M., Kedenko, L., Rao, M., Struchalin, M., Kleber, M.E., Cavalieri, M., Haun, M., Cornelis, M.C., Ciullo, M., Pirastu, M., de Andrade, M., McEvoy, M.A., Woodward, M., Adam, M., Cocca, M., Nauck, M., Imboden, M., Waldenberger, M., Pruijm, M., Metzger, M., Stumvoll, M., Evans, M.K., Sale, M.M., Kahonen, M., Boban, M., Bochud, M., Rheinberger, M., Verweij, N., Bouatia-Naji, N., Martin, N.G., Hastie, N., Probst-Hensch, N., Soranzo, N., Devuyst, O., Raitakari, O., Gottesman, O., Franco, O.H., Polasek, O., Gasparini, P., Munroe, P.B., Ridker, P.M., Mitchell, P., Muntner, P., Meisinger, C., Smit, J.H., ICBP Consortium, AGEN Consortium, CARDIOGRAM, CHARGe-Heart Failure Group, ECHOGen Consortium, Kovacs, P., Wild, P.S., Froguel, P., Rettig, R., Magi, R., Biffar, R., Schmidt, R., Middelberg, R.P., Carroll, R.J., Penninx, B.W., Scott, R.J., Katz, R., Sedaghat, S., Wild, S.H., Kardia, S.L., Ulivi, S., Hwang, S.J., Enroth, S., Kloiber, S., Trompet, S., Stengel, B., Hancock, S.J., Turner, S.T., Rosas, S.E., Stracke, S., Harris, T.B., Zeller, T., Zemunik, T., Lehtimaki, T., Illig, T., Aspelund, T., Nikopensius, T., Esko, T., Tanaka, T., Gyllensten, U., Volker, U., Emilsson, V., Vitart, V., Aalto, V., Gudnason, V., Chouraki, V., Chen, W.M., Igl, W., Marz, W., Koenig, W., Lieb, W., Loos, R.J., Liu, Y., Snieder, H., Pramstaller, P.P., Parsa, A., O'Connell, J.R., Susztak, K., Hamet, P., Tremblay, J., de Boer, I.H., Boger, C.A., Goessling, W., Chasman, D.I., Kottgen, A., Kao, W.H., Fox, C.S., Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat Commun, 7, 2016, 10023, 10.1038/ncomms10023 GWAS meta-analysis on eGFR in 133 413 individuals showed that the previously identified rs12917707 in UMOD gene was associated with eGFR also in diabetic subjects, and suggests that also the other eGFR loci may be relevant for diabetic individuals.
17. Fioretto, P., Mauer, M., Histopathology of diabetic nephropathy. Semin Nephrol 27 (2007), 195–207 pii:S0270-9295(07)00014-9.
18. Todd, J.N., Dahlstrom, E.H., Salem, R.M., Sandholm, N., Forsblom, C., FinnDiane Study Group, McKnight, A.J., Maxwell, A.P., Brennan, E., Sadlier, D., Godson, C., Groop, P.H., Hirschhorn, J.N., Florez, J.C., Genetic evidence for a causal role of obesity in diabetic kidney disease. Diabetes 64 (2015), 4238–4246, 10.2337/db15-0254 This Mendelian randomization study suggest that obesity is a causal risk factor for diabetic kidney disease and even ESRD, despite controversial results from the cross-sectional evaluation.
19. Panduru, N.M., Sandholm, N., Forsblom, C., Saraheimo, M., Dahlstrom, E.H., Thorn, L.M., Gordin, D., Tolonen, N., Waden, J., Harjutsalo, V., Bierhaus, A., Humpert, P.M., Groop, P.H., FinnDiane Study Group, Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes. Diabetes Care 38 (2015), 1130–1137, 10.2337/dc14-2330 This study identified strong genetic determinants for urinary KIM-1 levels, and the Mendelian randomisation suggests that KIM-1 is a causal risk factor for reduced renal function, even when adjusting for the level of albuminuria.
20. Ahola, A.J., Sandholm, N., Forsblom, C., Harjutsalo, V., Dahlstrom, E., Groop, P.H., FinnDiane Study Group, The serum uric acid concentration is not causally linked to diabetic nephropathy in type 1 diabetes. Kidney Int 91 (2017), 1178–1185 pii:S0085-2538(16)30757-8 Serum uric acid predicted progression of diabetic kidney disease, but using Mendelian randomisation with a genetic risk score for serum uric acid, this study suggested that serum uric acid may not be causally related to reduced renal function in diabetic individuals, which may challenge the clinical trials on the subject.
21. Monti, M.C., Lonsdale, J.T., Montomoli, C., Montross, R., Schlag, E., Greenberg, D.A., Familial risk factors for microvascular complications and differential male-female risk in a large cohort of American families with type 1 diabetes. J Clin Endocrinol Metab 92 (2007), 4650–4655, 10.1210/jc.2007-1185.
22. Arar, N.H., Freedman, B.I., Adler, S.G., Iyengar, S.K., Chew, E.Y., Davis, M.D., Satko, S.G., Bowden, D.W., Duggirala, R., Elston, R.C., Guo, X., Hanson, R.L., Igo, R.P. Jr., Ipp, E., Kimmel, P.L., Knowler, W.C., Molineros, J., Nelson, R.G., Pahl, M.V., Quade, S.R., Rasooly, R.S., Rotter, J.I., Saad, M.F., Scavini, M., Schelling, J.R., Sedor, J.R., Shah, V.O., Zager, P.G., Abboud, H.E., Family Investigation of Nephropathy and Diabetes Research Group, Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci 49 (2008), 3839–3845, 10.1167/iovs.07-1633.
23. Hietala, K., Forsblom, C., Summanen, P., Groop, P.H., FinnDiane Study Group, Heritability of proliferative diabetic retinopathy. Diabetes 57 (2008), 2176–2180, 10.2337/db07-1495.
24. Abhary, S., Hewitt, A.W., Burdon, K.P., Craig, J.E., A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes 58 (2009), 2137–2147, 10.2337/db09-0059.
25. 1 ) transporters found association with diabetic retinopathy, and when combined with replication studies, the variants were genome-wide significantly associated with the joint microvascular endpoint of retinopathy and ESRD.
26. Fu, Y.P., Hallman, D.M., Gonzalez, V.H., Klein, B.E., Klein, R., Hayes, M.G., Cox, N.J., Bell, G.I., Hanis, C.L., Identification of diabetic retinopathy genes through a genome-wide association study among Mexican-Americans from Starr County, Texas. J Ophthalmol, 2010, 2010, 10.1155/2010/861291 Epub 2010 Sep 2.
27. Grassi, M.A., Tikhomirov, A., Ramalingam, S., Below, J.E., Cox, N.J., Nicolae, D.L., Genome-wide meta-analysis for severe diabetic retinopathy. Hum Mol Genet 20 (2011), 2472–2481, 10.1093/hmg/ddr121.
28. Huang, Y.C., Lin, J.M., Lin, H.J., Chen, C.C., Chen, S.Y., Tsai, C.H., Tsai, F.J., Genome-wide association study of diabetic retinopathy in a Taiwanese population. Ophthalmology 118 (2011), 642–648, 10.1016/j.ophtha.2010.07.020.
29. Sheu, W.H., Kuo, J.Z., Lee, I.T., Hung, Y.J., Lee, W.J., Tsai, H.Y., Wang, J.S., Goodarzi, M.O., Klein, R., Klein, B.E., Ipp, E., Lin, S.Y., Guo, X., Hsieh, C.H., Taylor, K.D., Fu, C.P., Rotter, J.I., Chen, Y.D., Genome-wide association study in a Chinese population with diabetic retinopathy. Hum Mol Genet 22 (2013), 3165–3173, 10.1093/hmg/ddt161.
30. Awata, T., Yamashita, H., Kurihara, S., Morita-Ohkubo, T., Miyashita, Y., Katayama, S., Mori, K., Yoneya, S., Kohda, M., Okazaki, Y., Maruyama, T., Shimada, A., Yasuda, K., Nishida, N., Tokunaga, K., Koike, A., A genome-wide association study for diabetic retinopathy in a Japanese population: potential association with a long intergenic non-coding RNA. PLOS ONE, 9, 2014, e111715, 10.1371/journal.pone.0111715.
31. Burdon, K.P., Fogarty, R.D., Shen, W., Abhary, S., Kaidonis, G., Appukuttan, B., Hewitt, A.W., Sharma, S., Daniell, M., Essex, R.W., Chang, J.H., Klebe, S., Lake, S.R., Pal, B., Jenkins, A., Govindarjan, G., Sundaresan, P., Lamoureux, E.L., Ramasamy, K., Pefkianaki, M., Hykin, P.G., Petrovsky, N., Brown, M.A., Gillies, M.C., Craig, J.E., Genome-wide association study for sight-threatening diabetic retinopathy reveals association with genetic variation near the GRB2 gene. Diabetologia 58 (2015), 2288–2297, 10.1007/s00125-015-3697-2 GWAS on retinopathy in Australian individuals with T2D found variants near GRB2 gene associated with retinopathy. The findings replicated in individuals with T1D, T2D, and Indian individuals with T2D, resulting in a genome-wide significant association after meta-analysis.
32. McAuley, A.K., Wang, J.J., Dirani, M., Connell, P.P., Lamoureux, E., Hewitt, A.W., Replication of genetic loci implicated in diabetic retinopathy. Invest Ophthalmol Vis Sci 55 (2014), 1666–1671, 10.1167/iovs.13-13559.
33. Hosseini, S.M., Boright, A.P., Sun, L., Canty, A.J., Bull, S.B., Klein, B.E., Klein, R., DCCT/EDIC Research Group, Paterson, A.D., The association of previously reported polymorphisms for microvascular complications in a meta-analysis of diabetic retinopathy. Hum Genet 134 (2015), 247–257, 10.1007/s00439-014-1517-2.
34. Cheung, C.Y., Hui, E.Y., Lee, C.H., Kwok, K.H., Gangwani, R.A., Li, K.K., Chan, J.C., Woo, Y.C., Chow, W.S., Yuen, M.M., Wong, R.L., Fong, C.H., Xu, A., Wong, D.S., Sham, P.C., Lam, K.S., Impact of genetic loci identified in Genome-Wide Association Studies on diabetic retinopathy in Chinese patients with type 2 diabetes. Invest Ophthalmol Vis Sci 57 (2016), 5518–5524, 10.1167/iovs.16-20094.
35. Shtir, C., Aldahmesh, M.A., Al-Dahmash, S., Abboud, E., Alkuraya, H., Abouammoh, M.A., Nowailaty, S.R., Al-Thubaiti, G., Naim, E.A., ALYounes, B., Binhumaid, F.S., ALOtaibi, A.B., Altamimi, A.S., Alamer, F.H., Hashem, M., Abouelhoda, M., Monies, D., Alkuraya, F.S., Exome-based case–control association study using extreme phenotype design reveals novel candidates with protective effect in diabetic retinopathy. Hum Genet 135 (2016), 193–200, 10.1007/s00439-015-1624-8.
36. Ung, C., Sanchez, A.V., Shen, L., Davoudi, S., Ahmadi, T., Navarro-Gomez, D., Chen, C.J., Hancock, H., Penman, A., Hoadley, S., Consugar, M., Restrepo, C., Shah, V.A., Arboleda-Velasquez, J.F., Sobrin, L., Gai, X., Kim, L.A., Whole exome sequencing identification of novel candidate genes in patients with proliferative diabetic retinopathy. Vis Res, 2017 pii:S0042-6989(17)30054-8.
37. Tesfaye, S., Boulton, A.J., Dyck, P.J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R.A., Spallone, V., Vinik, A., Bernardi, L., Valensi, P., Toronto Diabetic Neuropathy Expert Group, Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33 (2010), 2285–2293, 10.2337/dc10-1303.
38. Wu, S., Han, Y., Hu, Q., Zhang, X., Cui, G., Li, Z., Guan, Y., Effects of common polymorphisms in the MTHFR and ACE genes on diabetic peripheral neuropathy progression: a meta-analysis. Mol Neurobiol, 2016, 10.1007/s12035-016-9823-4.
39. Meng, W., Deshmukh, H.A., van Zuydam, N.R., Liu, Y., Donnelly, L.A., Zhou, K., Wellcome Trust Case Control Consortium 2 (WTCCC2), Surrogate Markers for Micro- and Macro-Vascular Hard Endpoints for Innovative Diabetes Tools (SUMMIT) Study Group, Morris, A.D., Colhoun, H.M., Palmer, C.N., Smith, B.H., A genome-wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic pain. Eur J Pain 19 (2015), 392–399, 10.1002/ejp.560 The first GWAS on painful neuropathy identified 19% of the eligible cohort having painful neuropathy, indicated 11% heritability for the trait, and suggested a genetic association near GFRA2.
40. Meng, W., Deshmukh, H.A., Donnelly, L.A., Wellcome Trust Case Control Consortium 2 (WTCCC2), Surrogate markers for Micro- and Macro-vascular hard endpoints for Innovative diabetes Tools (SUMMIT) study group, Torrance, N., Colhoun, H.M., Palmer, C.N., Smith, B.H., A Genome-wide Association Study provides evidence of sex-specific involvement of Chr1p35.1 (ZSCAN20-TLR12P) and Chr8p23.1 (HMGB1P46) with diabetic neuropathic pain. EBioMedicine 2 (2015), 1386–1393, 10.1016/j.ebiom.2015.08.001.
41. Tuomilehto, J., Borch-Johnsen, K., Molarius, A., Forsen, T., Rastenyte, D., Sarti, C., Reunanen, A., Incidence of cardiovascular disease in type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia 41 (1998), 784–790.
42. Earle, K., Walker, J., Hill, C., Viberti, G., Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 326 (1992), 673–677, 10.1056/NEJM199203053261005.
43. Lange, L.A., Bowden, D.W., Langefeld, C.D., Wagenknecht, L.E., Carr, J.J., Rich, S.S., Riley, W.A., Freedman, B.I., Heritability of carotid artery intima-medial thickness in type 2 diabetes. Stroke 33 (2002), 1876–1881.
44. Qi, L., Parast, L., Cai, T., Powers, C., Gervino, E.V., Hauser, T.H., Hu, F.B., Doria, A., Genetic susceptibility to coronary heart disease in type 2 diabetes: 3 independent studies. J Am Coll Cardiol 58 (2011), 2675–2682.
45. Cox, A.J., Hsu, F.C., Ng, M.C., Langefeld, C.D., Freedman, B.I., Carr, J.J., Bowden, D.W., Genetic risk score associations with cardiovascular disease and mortality in the Diabetes Heart Study. Diabetes Care 37 (2014), 1157–1164, 10.2337/dc13-1514.
46. Qi, L., Qi, Q., Prudente, S., Mendonca, C., Andreozzi, F., di, P.N., Sturma, M., Novelli, V., Mannino, G.C., Formoso, G., Gervino, E.V., Hauser, T.H., Muehlschlegel, J.D., Niewczas, M.A., Krolewski, A.S., Biolo, G., Pandolfi, A., Rimm, E., Sesti, G., Trischitta, V., Hu, F., Doria, A., Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. JAMA 310 (2013), 821–828.
47. Shah, H.S., Gao, H., Morieri, M.L., Skupien, J., Marvel, S., Pare, G., Mannino, G.C., Buranasupkajorn, P., Mendonca, C., Hastings, T., Marcovina, S.M., Sigal, R.J., Gerstein, H.C., Wagner, M.J., Motsinger-Reif, A.A., Buse, J.B., Kraft, P., Mychaleckyj, J.C., Doria, A., Genetic predictors of cardiovascular mortality during intensive glycemic control in type 2 diabetes: findings from the ACCORD clinical trial. Diabetes Care 39 (2016), 1915–1924, 10.2337/dc16-0285 This GWAS study identified two genetic risk factors for cardiovascular mortality within intensively treated diabetic individuals, with each variant associated with threefold risk of mortality. Supporting evidence for mortality under tight glycemic control was obtained from two other studies.
48. Shah, H.S., Morieri, M.L., Marcovina, S.M., Sigal, R.J., Gerstein, H.C., Wagner, M.J., Motsinger-Reif, A.A., Buse, J.B., Kraft, P., Mychaleckyj, J.C., Doria, A., Modulation of GLP-1 levels by a genetic variant that regulates the cardiovascular effects of intensive glycemic control in ACCORD. Diabetes Care, 2017, 10.2337/dc17-1638.
49. Chheda, H., Palta, P., Pirinen, M., McCarthy, S., Walter, K., Koskinen, S., Salomaa, V., Daly, M., Durbin, R., Palotie, A., Aittokallio, T., Ripatti, S., Whole-genome view of the consequences of a population bottleneck using 2926 genome sequences from Finland and United Kingdom. Eur J Hum Genet 25 (2017), 477–484, 10.1038/ejhg.2016.205.
50. Bell, C.G., Teschendorff, A.E., Rakyan, V.K., Maxwell, A.P., Beck, S., Savage, D.A., Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med Genomics, 3, 2010, 33, 10.1186/1755-8794-3-33.
51. Agardh, E., Lundstig, A., Perfilyev, A., Volkov, P., Freiburghaus, T., Lindholm, E., Ronn, T., Agardh, C.D., Ling, C., Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy. BMC Med, 13, 2015, 182, 10.1186/s12916-015-0421-5 Epigenome-wide DNA methylation study on 28 cases with diabetic retinopathy and 30 non-PDR controls identified differential methylation in 233 genes.